Thus, NKX6.3 inactivation in gastric mucosa may increase activity of NF-kB and DNMT1 and reduce Hace1 expression, subsequently progressing to atrophy, intestinal metaplasisa and cancer. The gene discussed is HACE1; the disease is cancer.